Otolaryngology · East Lansing, MI
NPI
1679537278
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1500 Abbot Rd, Suite 400
East Lansing, MI, 48823
Phone (517) 332-0100
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,657 services
Medicare patients, 2024
288
Average age 73
Drug cost, 2024
$26K
933 prescriptions
Company payments, 2025
$753
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Lebeda was code 95165 (treatment - miscellaneous), 447 times for 21 patients. In total Mark D Lebeda billed 1,657 services in 49 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 447 | 21 | $8.85 | $3,957 |
| 99213 Office E&M - Established | Office | 247 | 162 | $59.56 | $15K |
| 95117 Treatment - Miscellaneous | Office | 240 | 42 | $7.81 | $1,875 |
| 95024 Test - Miscellaneous | Office | 167 | 22 | $4.59 | $767 |
| 31231 Nasal/Sinus Endoscopy | Office | 76 | 60 | $127.50 | $9,690 |
| 99214 Office E&M - Established | Office | 69 | 56 | $84.68 | $5,843 |
| 99203 Office E&M - New | Office | 51 | 51 | $59.41 | $3,030 |
| 31575 Other Organ Systems | Office | 35 | 32 | $86.01 | $3,010 |
| 99204 Office E&M - New | Office | 14 | 14 | $118.36 | $1,657 |
By year: 2022 $77K for 2,471 services; 2023 $88K for 2,222 services; 2024 $88K for 1,657 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Lebeda prescribed most often to Medicare patients was Ipratropium Bromide, with 243 prescriptions and refills. In total Mark D Lebeda wrote 933 Medicare prescriptions that cost $26K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 243 | 279 | 103 | $6,849 |
| Mupirocin Generic | 70 | 72 | 48 | $464 |
| Omeprazole Generic | 57 | 111 | 20 | $619 |
| Famotidine Generic | 54 | 97 | 17 | $996 |
| Fluticasone Propionate Generic | 46 | 62 | 17 | $1,067 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 40 | 83 | 12 | $357 |
| Ofloxacin Generic | 36 | 36 | 27 | $600 |
| Methylprednisolone Generic | 33 | 33 | 28 | $215 |
| Doxycycline Monohydrate Generic | 28 | 28 | 20 | $405 |
| Mometasone Furoate Generic | 28 | 30 | 23 | $207 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 17 | 17 | 16 | $97.63 |
| Cefdinir Generic | 17 | 17 | 14 | $265 |
| Sulfacetamide-Prednisolone Sulfacetamide/Prednisolone Sp | 16 | 16 | Under 11 | $222 |
| Ondansetron Odt Ondansetron | 16 | 16 | 15 | $70.29 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 16 | 17 | Under 11 | $2,090 |
Brand drugs: 42 claims; generic drugs: 891 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Lebeda $753 ($753 in general payments such as food, travel and fees) from 10 companies. The largest payer was Integra LifeSciences Corporation with $175.
| Company | Payments | Amount |
|---|---|---|
| Integra LifeSciences Corporation IART | 4 | $175 |
| Stryker Corporation SYK | 2 | $175 |
| GlaxoSmithKline, LLC. GSK | 7 | $121 |
| Neurent Medical Limited | 2 | $58.7 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $55.76 |
| Genzyme Corporation SNY | 2 | $48.69 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 2 | $43.19 |
| Merck Sharp & Dohme LLC MRK | 1 | $32.82 |
| ConvaTec Inc. CTEC.L | 1 | $24.13 |
| Cochlear Americas | 1 | $18.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.